Evidence map›Paper›PMID 34586862›Full record

ArticleJournal of virology2021

Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye.

Robert J Watson, Julia Tree, Susan A Fotheringham, Yper Hall, Xiaofeng Dong, Kimberley Steeds, Jade Gouriet, Francisco J Salguero, Christopher Burton, James Pitman and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Characterization of Atypical Ebola Virus Disease in Ferrets.bioRxiv : the preprint server for biology · 2026
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Atypical Ebola Virus Disease in a Rhesus Macaque.The Journal of infectious diseases · 2023
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 2 countries.

Robert J WatsonUK Health Security Agency, Porton Down, Salisbury, United Kingdom.ORCID 0000-0003-3146-3457
Julia TreeUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Susan A FotheringhamUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Yper HallUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Xiaofeng DongInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpoolgrid.10025.36, Liverpool, United Kingdom.
Kimberley SteedsUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Jade GourietUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Francisco J SalgueroUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Christopher BurtonUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
James PitmanUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Linda EasterbrookUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Kevin S RichardsUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Jane BurtonUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Kevin BewleyUK Health Security Agency, Porton Down, Salisbury, United Kingdom.ORCID 0000-0002-9078-6734
Christine BruceUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Julian A HiscoxInstitute of Infection, Veterinary and Ecological Sciences, University of Liverpoolgrid.10025.36, Liverpool, United Kingdom.
Miles W CarrollUK Health Security Agency, Porton Down, Salisbury, United Kingdom.
Simon G P FunnellUK Health Security Agency, Porton Down, Salisbury, United Kingdom.ORCID 0000-0002-4254-2751
UK Health Security Agency · GBAgency for Science, Technology and Research · SGUniversity of Liverpool · GBUniversity of Oxford · GB

Funding

HHS | Biomedical Advanced Research and Development Authority (BARDA) HHS0100201700016IHHS | U.S. Food and Drug Administration (FDA) HHSF223201710194C
6 · The paper itself

Abstract

Filoviruses cause high-consequence infections with limited approved medical countermeasures (MCMs). MCM development is dependent upon well-characterized animal models for the assessment of antiviral agents and vaccines. Following large-scale Ebola virus (EBOV) disease outbreaks in Africa, some survivors are left with long-term sequelae and persistent virus in immune-privileged sites for many years. We report the characterization of the ferret as a model for Ebola virus infection, reproducing disease and lethality observed in humans. The onset of clinical signs is rapid, and EBOV is detected in the blood, oral, and rectal swabs and all tissues studied. We identify viral RNA in the eye (a site of immune privilege) and report on specific genomic changes in EBOV present in this structure. Thus, the ferret model has utility in testing MCMs that prevent or treat long-term EBOV persistence in immune-privileged sites.

Indexed as

Evolution, MolecularAnimalsAntibodies, ViralDisease Models, AnimalEbolavirusEyeFemaleFerretsHemorrhagic Fever, EbolaMaleRNA, ViralAntibodies, ViralRNA, Viralanimal modelBARDAEbolaEBOVeyeferretfilovirusimmune privilegedmedical countermeasurePHEPorton DownUKHSA

Identifiers

PMID34586862
PMCPMC8610581
OpenAlexW3203746373

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.